T2 Dynamic Duo

💉 T2 — Research Peptide

T2 is a synthetic research peptide developed as a dual GIP and GLP-1 receptor agonist, studied for its potential role in glucose metabolism, weight regulation, and metabolic optimization.

Research Focus & Mechanism

• Dual receptor activation:

o GIP (Glucose-Dependent Insulinotropic Polypeptide): Investigated for enhancing insulin sensitivity and fat metabolism

o GLP-1 (Glucagon-Like Peptide-1): Studied for slowing gastric emptying, reducing appetite, and supporting glycemic control

• Together, these pathways are explored for their synergistic effects on metabolic regulation, body composition, and energy balance

Research Insights

• Preclinical and clinical research shows T2 may significantly improve glucose tolerance and reduce body fat mass

• Studied for potential benefits in obesity, insulin resistance, and cardiovascular health research models

• Demonstrated enhanced weight reduction and metabolic efficiency compared to single-agonist peptides like semaglutide

Potential Research Applications

• Metabolic optimization and weight management models

• Glucose and insulin regulation research

• Peptide synergy studies with compounds like AOD-9604, Cagrilintide, or Retatrutide

🔍 Cagrilintide — Research Peptide

Cagrilintide is a synthetic research peptide and a long acting analogue of the hormone amylin. It has been developed to investigate pathways of appetite, satiety, energy balance, and metabolic regulation.

Research Focus & Mechanism

• It mimics endogenous amylin (islet amyloid polypeptide), which is secreted by pancreatic β cells along with insulin and plays a role in regulating food intake and gastric emptying. 

• Cagrilintide is modified for extended half life (due to fatty acid chain linking etc) so that it can serve in once weekly dosing models in research. 

• Through activation of the amylin receptor (and via cross activation of calcitonin receptors) it is studied for:

o increasing satiety / reducing appetite

o slowing gastric emptying

o influencing caloric intake, energy expenditure, and weight/fat mass in metabolic models

o potential synergy with GLP 1 receptor agonists in weight management research.

⚠️ Disclaimer:

T3 and CAG are intended for laboratory research purposes only.

It is not approved for human use, consumption, or medical treatment.